Our Pipeline
Our unique IND engine has helped us identify novel pathways and targets in immuno-oncology and other areas.
Five Prime Programs
Bemarituzumab
FGFR2b antibody
FIGHT trial (with chemo) in 1L gastric/GEJ cancer
FPA150
B7-H4 antibody
Breast, ovarian and endometrial cancers
FPT155
CD80-Fc Fusion
Multiple tumor settings
Multiple tumor settings
Partnered Programs
Cabiralizumab
CSF-1R antibody
Cabira + OPDIVO® in 2L pancreatic cancer
Cabira + OPDIVO in 1L pancreatic maintenance
Cabira + OPDIVO in resectable biliary tract cancer
Cabira + anti-CD40 + OPDIVO in melanoma, NSCLC and RCC
BMS-986258
TIM-3 antibody
Multiple tumor settings
Multiple tumor settings
